Cytokines and thrombosis

Journal of Cardiovascular Pharmacology

Volumn 25, Issue , 1995, Pages S13-S19

  Dosquet, Christine ^a   Weill, Dominique ^a   Wautier, Jean Luc ^a  

^a HÔPITAL LARIBOISIÈRE   (France)

Author keywords

Cytokine inhibitors; Cytokines; Endothelial cells; Interleukin 6; Leukocyte adhesion molecules

Indexed keywords

AURANOFIN; AUROTHIOMALATE; CELL ADHESION MOLECULE; CYTOKINE; CYTOKINE ANTIBODY; CYTOKINE INHIBITOR; DEXAMETHASONE; GLUCOCORTICOID; INTERLEUKIN 1; INTERLEUKIN 6; ISOBUTYLMETHYLXANTHINE; MONOCLONAL ANTIBODY; PENTOXIFYLLINE; RECOMBINANT PROTEIN; THEOPHYLLINE; TUMOR NECROSIS FACTOR; TUMOR NECROSIS FACTOR ANTIBODY; UNCLASSIFIED DRUG;

ANIMAL MODEL; ATHEROSCLEROSIS; CONFERENCE PAPER; ENDOTHELIUM CELL; HUMAN; IMMUNITY; INFLAMMATION; LEUKOCYTE; LEUKOCYTE ACTIVATION; LEUKOCYTE ADHERENCE; MEDIATOR; NONHUMAN; PRIORITY JOURNAL; THROMBOCYTE AGGREGATION; THROMBOSIS;

ANIMALS; CYTOKINES; ENDOTHELIUM, VASCULAR; HUMANS; THROMBOSIS;

EID: 0029555505     PISSN: 01602446     EISSN: 15334023     Source Type: Journal    
DOI: 10.1097/00005344-199500252-00004     Document Type: Article

References (65)

1. Pober JS. Cytokine-mediated activation of vascular endothelium. Physiology and pathology. Am J Pathol 1988;133:426-33.
2. Bevilacqua MP. Endothelial-leukocyte adhesion molecules. Annu Rev Immunol 1993;11:767-804.
3. Mantovani A, Dejana E. Cytokines as communication signals between leukocytes and endothelial cells. Immunol Today 1989;10:370-5.
4. Baumann H, Gauldie J. The acute phase response. Immunol Today 1994;15:74-80.
5. Onda M, Toba M, Andoh T, Shirota A. Ultrastructural studies of experimental shock in the liver and spleen: therapeutic effects of low dose of heparin on reticuloendothelial disturbance. Circ Shock 1986;18:11-9.
6. Cannon JG, Tompkins R, Gelfand JA, et al. Circulating interleukin-1 and tumor necrosis factor in septic shock and experimental endotoxin fever. J Infect Dis 1990;161:79-84.
7. Sue-Lin GHM, Johnston D, McMahon MJ, Philips PR, Davies JA. Preoperative identification of patients at high risk of deep venous thrombosis after elective major abdominal surgery. Lancet 1986;1:1173-6.
8. Sakamoto K, Arakana H, Mita S, et al. Elevation of circulating interleukin-6 after surgery: factors influencing the serum level. Cytokine 1994;6:181-6.
9. Rickies FR, Edward RL. Activation of blood coagulation in cancer: Trousseau's syndrome revisited. Blood 1983;62:I-4-31.
10. Dosquet C, Schaetz A, Faucher C, et al. Tumor necrosis factor-α, interleukin-1β and interleukin-6 in patients with renal cell carcinoma. Eur J Cancer 1994;30A: 162-7.
11. Dosquet C, Feugeas JP, Lioté F, Wautier JL. Vasculitis, antiphospholipid antibodies and increased blood level of TNFa. Blood 1990;76:504a.
12. Mosesson MW, Wautier JL, Amrani D, Dervichian M, Cattan D. Evidence for circulating fibrin in familial Mediterranean fever. J Lab Clin Med 1982;99:559-67.
13. Courillon-Mallet A, Bevilacqua M, Wautier JL, Dervichian M, Cattan D, Caen JP. Increased procoagulant response of monocyte from patients wtih familial Mediterranean fever. Thromb Haemost 1986;28:339-43.
14. Navry CPJ, Teppo AM. Raised serum levels of cachectin/tumor necrosis factor α in renal allograft rejection. J Exp Med 1987;166:1132-7.
15. Libby P, Clinton SK. Cytokines as mediators of vascular pathology. Nouv Rev Fr Hematol 1992;34:S47-S53.
16. Delomenie C, Wautier MP, Chappey O, Wautier JL. Modulation of human endothelial cell activation by antiproliferative cytokines: exploration of arachidonic acid and intracellular cytokine pathways as possible mechanisms of action. Exp Cell Res 1993;207:122-3.
17. Dosquet C, Wautier JL. Blood monocyte adhesion to vascular endothelial cells. Implication in vascular pathology. Clin Hemorrheol 1992;12:817-29.
18. Edgington TS, Mackman N, Brand K, Ruf W. The structural biology of expression and function of tissue factor. Thromb Haemost 1991;66:67-79.
19. Bevilacqua MP, Pober JS, Majeau GR, Fiers W, Cotran RS, Gimbrone MA Jr. Recombinant tumor necrosis factor induced procoagulant activity in cultured human vascular endothelium: characterization and comparison with the actions of interleukin I. Proc Natl Acad Sci USA 1986;83:4533-7.
20. Nawroth PP, Handley CT, Esmon C, Stern D. Interleukin-1 induces endothelial cell procoagulant activity while suppressing cell surface anticoagulant activity. Proc Natl Acad Sci USA 1986;83:3460-4.
21. Scarpati EM, Sadler JE. Regulation of endothelial cell coagulant properties. Modulation of tissue factor, plasminogen activator inhibitors and thrombomodulin by phorbolester 12-myristate 13-acetate and tumor necrosis factor. J Biol Chem 1989;264:20705-13.
22. Palelog EM, Crossman DC, McVey JH, Pearson JD. Differential regulation by cytokines of constitutive and stimulated secretion of von Willebrand factor from endothelial cells. Blood 1990;75:688-95.
23. Lentz SR, Tsiang M, Sadler JE. Regulation of thrombomodulin by tumor necrosis factor-α: comparison of transcriptional and posttranscriptional mechanisms. Blood 1991;77:542-50.
24. Moore KL, Esmon CT, Esmon NL. Tumor necrosis factor leads to the internalization and degradation of thrombomodulin from the surface of bovine aortic endothelial cells in culture. Blood 1989;73:159-65.
25. Van Hinsbergh VWM, Kooistra T, Van Den Berg EA, Princen HMG, Firs W, Emeis JJ. Tumor necrosis factor increases the production of plasminogen activator inhibitor in human endothelial cells in vitro and in rats in vivo. Blood 1988;72:1467-73.
26. Bevilacqua MP, Schleef RR, Gimbrone MA, Jr, Loskutoff DJ. Regulation of the fibrinolytic system of cultured human vascular endothelium by interleukin-1. J Clin Invest 1986;78:587-91.
27. Dejana E, Brevario F, Balconi G, et al. Stimulation of prostacyclin synthesis in vascular cells by mononuclear cell products. Blood 1984;64:1280-3.
28. Ernst E, Hammerschmidt DE, Bagge U, Matrai A, Dormandy JA. Leukocytes and the risk of ischemic diseases. JAMA 1987;257:2318-24.
29. Springer TA. Traffic signals for lymphocyte recirculation and leukocyte emigration: the multistep paradigm. Cell 1994;12:817-29.
30. Etzioni A, Gershoni-Baruch R, Harlan JM. Sialyl Lewis X and neutrophil aggregation. Blood 1994;83:876-7.
31. Rollins BJ, Yoshimura T, Leonard EJ, Pober JS. Cytokine activated human endothelial cells synthesize and secrete a monocyte chemoattractant, MCP-1/JE. Am J Pathol 1990;136:1229-33.
32. Wheeler ME, Luscinskas FW, Bevilacqua MP, Gimbrone MA, Jr. Cultured human endothelial cells stimulated with cytokines or endotoxin produce an inhibitor of leukocyte adhesion. J Clin Invest 1988;82:1211-8.
33. Wang J, Sica A, Peri G, et al. Expression of monocyte chemotactic protein and interleukin-8 by cytokine-activated human vascular smooth muscle cells. Arterioscler Thromb 1991;11:1166-74.
34. Tanaka Y, Adams DH, Shaw S. Proteoglycans on endothelial cells present adhesion-inducing cytokines to leukocytes. Immunol Today 1993;14:111-5.
35. Pattison J, Nelson PJ, Huie P, et al. RANTES chemokine expression in cell mediated transplant rejection of the kidney. Lancet 1994;343:209-11.
36. Horuk R. The interleukin-8 receptor family: from chemokines to malaria. Immunol Today 1994;15:169-74.
37. Clark SC, Kamen R. The human hematopoietic colony stimulating factors. Science 1987;236:1229-37.
38. Palace GP, Del Vecchio PJ, Horgan MJ, Malik AB. Release of tumor necrosis factor after pulmonary artery occlusion and reperfusion. Am Rev Respir Dis 1993;147:143-7.
39. Vedder NB, Winn RK, Rice CL, Chi EY, Arfors KE, Harlan JM. A monoclonal antibody to the adherence promoting leukocyte glycoprotein, CD18, reduces organ injury and improves survival from hemorrhagic shock and resuscitation in rabbits. J Clin Invest 1988;81:939-44.
40. Shager I, Jungi TW. Effect of human recombinant cytokines on the induction of macrophage procoagulant activity. Blood 1994;83:152-60.
41. Rothberger H, Barringer M, Meredith J. Increased tissue factor activity of monocytes/macrophages activated from canine renal allograft. Blood 1984;63:623-8.
42. Bauer KA, Ten Cate H, Barzegar S, Spriggs DR, Sherman ML, Rosenberg RD. Tumor necrosis factor infusions have a procoagulant effect on the hemostatic mechanism of humans. Blood 1989;74:165-72.
43. Van Deventer SJH, Bueller HR, Ten Cate JW, Aarden LA, Hack CE, Sturk A. Experimental endotoxemia in humans: analysis of cytokine release and coagulation, fibrinolytic and complement pathways. Blood 1990;76:2520-6.
44. Levi M, Ten Cate H, Bauer HA, et al. Inhibition of endotoxin-induced activation of coagulation and fibrinolysis by pentoxifylline or by a monoclonal anti-tissue factor antibody in chimpanzees. J Clin Invest 1994;93:114-20.
45. Vlassara H, Brownlee M, Manogue KR, Dinarello CA, Pasagian A. Cachectin/TNF and IL-1 induced by glucose-modified proteins: role in normal tissue remodeling. Science 1988;240:11546-8.
46. Esposito C, Gerlach H, Brett J, Stern D, Vlassara H. Endothelial receptor-mediated binding of glucose-modified albumin is associated with increased monolayer permeability and modulation of cell surface coagulant properties. J Exp Med 1989;170:1387-1407.
47. Jude B, Fontaine P. Modifications of monocyte procoagulant activity in diabetes mellitus. Semin Thromb Hemost 1991;17:445-7.
48. Buttrum SM, Hatton R, Nash GB. Selectin mediated rolling of neutrophils on immobilized platelets. Blood 1993;82:1165-74.
49. Pancre V, Pierce RJ, Fournier F, et al. Effect of ubiquitin on platelet function: possible identity with platelet activity suppressive lymphokine (PASL). Eur J Immunol 1991;21:2735-41.
50. Todoroki N, Wanatabe Y, Akaike T, et al. Enhancement by IL-1β and IFN-γ of platelet activation: adhesion to leukocyte via GMP140/PADGEM protein (CD62). Biochem Biophys Res Commun 1991;179:756-61.
51. Leeuwenberg JFM, Von Asmuth EJU, Jeunhomme TMAA, Buurman WA. IFN-γ regulates the expression of the adhesion molecule ELAM-1 and IL-6 production by human endothelial cells in vitro. J Immunol 1990;145:2110-4.
52. Steel DM, Whitehead AS. The major acute phase reactants: C-reactive protein, serum amyloid P component and serum amyloid A protein. Immunol Today 1994;15:81-8.
53. Peng J, Friese P, George JN, Dale GL, Burstein SA. Alteration of platelet function in dogs mediated by interleukin-6. Blood 1994;83:398-403.
54. Scarabin PY, Bara L, Ricard S, et al. Genetic variation at the β fibrinogen locus in relation to plasma fibrinogen concentrations and risk of myocardial infarction. The ECTIM study. Arterioscler Thromb 1993;13:886-91.
55. Windsor AC, Walsh CJ, Mullen PG, et al. Tumor necrosis factor-α blockade prevents neutrophil CD 18 receptor upregulation and attenuates acute lung injury in porcine sepsis without inhibition of neutrophil oxygen radical generation. J Clin Invest 1993;91:1459-68.
56. Bandara G, Mueller GM, Galea-Lauri J, et al. Intraarticular expression of biologically active interleukin 1-receptor-antagonist protein by ex vivo gene transfer. Proc Natl Acad Sci USA 1993;90:10764-8.
57. Kolls J, Peppel K, Silva M, Beutler B. Prolonged and effective blockade of tumor necrosis activity through adenovirus mediated gene transfer. Proc Natl Acad Sci USA 1994;91:215-9.
58. Kern JA, Lamb RJ, Reed JC, Daniele RP, Nowell PC. Dexamethasone inhibition of interleukin 1 beta production by human monocytes. Posttranscriptional mechanisms. J Clin Invest 1988;81:237-44.
59. Danis VA, Kulesz AJ, Nelson DS, Brooks PM. The effect of gold sodium thiomalate and auranofin on lipopolysaccharide-induced interleukin-1 production by blood monocytes in vitro: variation in healthy subjects and patients with arthritis. Clin Exp Immunol 1990;79:335-40.
60. Han J, Thompson P, Beutler B. Dexamethasone and pentoxifylline inhibit endotoxin-induced cachectin/tumor necrosis factor synthesis at separate points in the signaling pathway. J Exp Med 1990;172:391-1.
61. De Prost D, Ollivier V, Hakim J. Pentoxifylline inhibition of procoagulant activity generated by activated mononuclear phagocytes. Mol Pharmacol 1990;38:562-6.
62. Ollivier V, Houssaye S, Ternisien C, et al. Endotoxin-induced tissue factor messenger RNA in human monocytes is negatively regulated by a cyclic AMP-dependent mechanism. Blood 1993;81:973-9.
63. Strieter RM, Remick DG, Ward PA, et al. Cellular and molecular regulation of tumor necrosis factor-alpha production by pentoxifylline. Biochem Biophys Res Commun 1988;155:1230-6.
64. Zabel P, Schoenhartig MM, Wolter DT, Schade UF. Oxpentifylline in endotoxemia. Lancet 1989;2:1474-7.
65. Endres S, Fülle HJ. Cyclic nucleotides differentially regulate the synthesis of tumor necrosis factor-α and interleukin-β by human mononuclear cells. Immunology 1991;72:56-60.